Skip to main content

FDA issues voluntary recall of high blood pressure drug over cancer risks

WASHINGTON — The Food and Drug Administration is voluntarily recalling several drugs used to treat high blood pressure and heart failure that contain the ingredient valsartan.

The recall comes because an impurity, known as NDMA, was found in the recalled products. NDMA is known to cause cancer, the FDA said.

The agency said the presence of NDMA was unexpected and thought to be related to changes in the way the ingredient, valsartan, was manufactured.

The recalled products include valsartan produced by Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals.

The FDA has a specific list of impacted medications on its website.

The FDA said patients with the recalled products should contact their doctor and their pharmacist if their medication is included on the recall list.

The agency said it is continuing to investigate NDMA levels in the medicine and assessing the possible effect on patients who took the medicines.

FDA recalls children’s liquid pain reliever; local doctor says it’s time to spring clean your medicine cabinet

A Maryland doctor has important advice for parents, following the recall of some medicine for children. The Food and Drug Administration has recalled nearly 90,000 bottles of Taro Pharmaceuticals' Children's Ibuprofen Oral Suspension liquid pain reliever after customers reported they found a "gel-like mass" and black particles in the medication. The FDA says it's unlikely to cause health problems.
Read Next Story